Nuo Therapeutics, Inc. (AURX)

Gross Margin

66.14%

Quarterly · Period ending:

AURX logo

AURX Gross Margin

Latest reported66.14%
AURX Quarterly Gross Margin (84.82% → 66.14%)
High-resolution chart · PNG

AURX gross margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuo Therapeutics, Inc. Gross Margin — Quarterly
Period endingGross Margin
66.1411%
65.2574%
62.7599%
60.5927%
77.2423%
75.0153%
78.1165%
72.9064%
82.0889%
78.4331%
79.0026%
76.8267%
82.663%
82.9476%
82.8122%
83.0196%
0%
0%
0%
0%
0%
0%
0%
0%
-258.6939%
40.0359%
23.8537%
26.8424%
96.1936%
82.7663%
72.3641%
69.3616%
-41.5608%
-62.7617%
-47.0684%
-56.3519%
-71.3982%
-57.0393%
41.0813%
43.9646%
27.9301%
26.2369%
17.7338%
41.5906%
-9.9063%
21.1418%
18.4261%
21.2827%
14.1976%
15.3385%
43.9479%
45.0894%
48.2526%
43.2769%
73.4075%
71.8759%
75.4422%
53.2207%
54.1541%
52.7403%
55.914%
58.8076%
40.2662%
2.4008%
75.1271%
80.7694%
79.2778%
75.3334%
68.784%
78.188%
75.0883%
65.2275%
60.6354%
68.3735%
48.2413%
47.819%
36.2077%
61.1006%
45.7153%
45.7174%
33.3802%
56.2525%
33.1411%
43.0473%
38.3864%
36.381%
44.4025%
32.8729%
37.2173%
34.4475%
25.7462%
21.4521%
85.4941%
82.6016%
82.1906%
100%
100%
100%
100%
4.7225%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.